1. Home
  2. NTCT vs SRPT Comparison

NTCT vs SRPT Comparison

Compare NTCT & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetScout Systems Inc.

NTCT

NetScout Systems Inc.

N/A

Current Price

$33.16

Market Cap

2.3B

Sector

Technology

ML Signal

N/A

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

N/A

Current Price

$14.16

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NTCT
SRPT
Founded
1984
1980
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
1999
2000

Fundamental Metrics

Financial Performance
Metric
NTCT
SRPT
Price
$33.16
$14.16
Analyst Decision
Buy
Hold
Analyst Count
2
24
Target Price
★ $42.50
$21.86
AVG Volume (30 Days)
435.5K
★ 1.5M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 125.39
N/A
EPS
0.76
★ 2.78
Revenue
$891,820,000.00
★ $2,198,237,000.00
Revenue This Year
$4.76
N/A
Revenue Next Year
$2.48
N/A
P/E Ratio
$42.59
★ $5.26
Revenue Growth
N/A
★ N/A
52 Week Low
$25.29
$14.59
52 Week High
$45.28
$24.68

Technical Indicators

Market Signals
Indicator
NTCT
SRPT
Relative Strength Index (RSI) 37.65 28.61
Support Level $31.44 N/A
Resistance Level $34.14 $18.26
Average True Range (ATR) 1.43 0.84
MACD -0.13 -0.37
Stochastic Oscillator 26.99 0.48

Price Performance

Historical Comparison
NTCT
SRPT

About NTCT NetScout Systems Inc.

NetScout Systems Inc is engaged in providing enterprise network observability, carrier service assurance, cybersecurity, and Distributed Denial-of-Service (DDoS), protection solutions. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: